Lv2
110 积分 2022-08-10 加入
The global burden of IBD: from 2015 to 2025
9小时前
已完结
The biology of TREM receptors
2天前
已完结
TREM-1 multimerization is essential for its activation on monocytes and neutrophils
3天前
已完结
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience
5天前
已完结
CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation
11个月前
已完结
Data from AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1年前
已关闭
Interleukin-33 in health and disease
1年前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer
1年前
已完结
Abstract DDT02-03: AMG 509: A novel, humanized, half-Life extended, bispecific STEAP1 × CD3 T cell recruiting XmAb® 2+1 antibody
1年前
已关闭
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
1年前
已完结
皖公网安备34019202002308
